Literature DB >> 29122324

Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients.

Wessel M C M Vorselaars1, Emily L Postma2, Eric Mirallie3, Julien Thiery3, Mattan Lustgarten4, Jesse D Pasternak4, Rocco Bellantone5, Marco Raffaelli5, Thomas Fahey6, Menno R Vriens1, Laurent Bresler7, Laurent Brunaud7, Rasa Zarnegar8.   

Abstract

BACKGROUND: Intraoperative hemodynamic instability is a major challenge during adrenalectomy for pheochromocytoma. Typically, pheochromocytoma is performed laparoscopically either through the retroperitoneal or transperitoneal approach. We aimed to determine if the operative approach affects intraoperative hemodynamic instability during surgery for pheochromocytoma in a large multicenter multicenter cohort.
METHODS: Retrospective, multicenter analysis of consecutive patients with pheochromocytoma who underwent total unilateral laparoscopic adrenalectomy without conversion were included. Statistical analysis was performed using established intraoperative criteria for intraoperative hemodynamic instability: 1) systolic blood pressure >160 mm Hg; 2) systolic blood pressure > 200 mm Hg; 3) mean arterial pressure <60 mm Hg; 4) systolic blood pressure >160 mm Hg + mean arterial pressure <60 mm Hg; and 5) systolic blood pressure >200 mm Hg + mean arterial pressure <60 mm Hg; and 6) intravenous vasopressor + vasodilator.
RESULTS: In total, 341 patients met the inclusion criteria, 101 (29.6%) underwent retroperitoneal adrenalectomy and 240 (70.4%) transperitoneal adrenalectomy. Multivariate analysis showed that retroperitoneal adrenalectomy carries greater risk for mean arterial pressure <60 mm Hg (odds ratio 6.255, confidence interval 1.134-34.235, P = .035) compared with transperitoneal adrenalectomy. Overall and cardiovascular morbidity rates were comparable between the 2 approaches. The medical center was a significant independent influencing factor for all 6 intraoperative hemodynamic instability definitions.
CONCLUSION: Variability in institutional management of pheochromocytoma intraoperatively has significant impact on all 6 intraoperative hemodynamic instability definitions. Standardization of anesthesia should be considered to reduce this variability.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29122324     DOI: 10.1016/j.surg.2017.05.029

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Effects of pretreatment with terazosin and valsartan on intraoperative haemodynamics in patients with phaeochromocytoma.

Authors:  Qingrong Ji; Feng Li; Xianzhao Zhang; Yuqiang Wang; Cunfei Liu; Ying Chang
Journal:  Eur J Hosp Pharm       Date:  2020-09-07

2.  The association between the type of anesthesia and hemodynamic instability during pheochromocytoma surgery: a retrospective cohort study.

Authors:  Won Woong Kim; Doo-Hwan Kim; Jae Won Cho; Cheong-Sil Rah; Yu-Mi Lee; Ki-Wook Chung; Jung-Min Koh; Seung Hun Lee; Suck Joon Hong; Yeon Ju Kim; Tae-Yon Sung
Journal:  Surg Endosc       Date:  2022-01-10       Impact factor: 3.453

3.  Is laparoscopic left adrenalectomy with the anterior submesocolic approach for Conn's or Cushing's syndrome equally safe and effective as the lateral and anterior ones?

Authors:  Andrea Balla; Silvia Quaresima; Livia Palmieri; Monica Ortenzi; Emilia Sbardella; Giulia Puliani; Andrea M Isidori; Mario Guerrieri; Alessandro M Paganini
Journal:  Surg Endosc       Date:  2018-11-19       Impact factor: 4.584

4.  Endocrine hypertension secondary to adrenal tumors: clinical course and predictive factors of clinical remission.

Authors:  Uriel Clemente-Gutiérrez; Rafael H Pérez-Soto; Juan D Hernández-Acevedo; Nicole M Iñiguez-Ariza; Enrique Casanueva-Pérez; Juan Pablo Pantoja-Millán; Mauricio Sierra-Salazar; Miguel F Herrera; David Velázquez-Fernández
Journal:  Langenbecks Arch Surg       Date:  2021-06-23       Impact factor: 3.445

5.  Risk factors for hemodynamic instability during laparoscopic pheochromocytoma resection: a retrospective cohort study.

Authors:  Magdalena Pisarska-Adamczyk; Karolina Zawadzka; Krzysztof Więckowski; Krzysztof Przęczek; Piotr Major; Michał Wysocki; Piotr Małczak; Michał Pędziwiatr
Journal:  Gland Surg       Date:  2021-03

6.  The determination of real fluid requirements in laparoscopic resection of pheochromocytoma using minimally invasive hemodynamic monitoring: a prospectively designed trial.

Authors:  Martin B Niederle; Edith Fleischmann; Barbara Kabon; Bruno Niederle
Journal:  Surg Endosc       Date:  2019-04-11       Impact factor: 4.584

7.  Comparison of the retroperitoneal versus Transperitoneal laparoscopic Adrenalectomy perioperative outcomes and safety for Pheochromocytoma: a meta-analysis.

Authors:  Yu-Li Jiang; Lu-Jie Qian; Zhen Li; Kang-Er Wang; Xie-Lai Zhou; Jin Zhou; Chun-Hua Ye
Journal:  BMC Surg       Date:  2020-01-13       Impact factor: 2.102

8.  Comparison of Perioperative Outcomes of Robotic-Assisted vs Laparoscopic Adrenalectomy for Pheochromocytoma: A Meta-Analysis.

Authors:  Zhongyou Xia; Jinze Li; Lei Peng; Xiaoying Yang; Yulai Xu; Xianhui Li; Yunxiang Li; Zongping Zhang; Ji Wu
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

9.  Comparison of robot-assisted retroperitoneal laparoscopic adrenalectomy versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: a single-centre retrospective study.

Authors:  Sheng-Qiang Fu; Chang-Shui Zhuang; Xiao-Rong Yang; Wen-Jie Xie; Bin-Bin Gong; Yi-Fu Liu; Ji Liu; Ting Sun; Ming Ma
Journal:  BMC Surg       Date:  2020-10-07       Impact factor: 2.102

10.  Hemodynamic stability during adrenalectomy for pheochromocytoma: A case control study of posterior retroperitoneal vs lateral transperitoneal approaches.

Authors:  Eun Jeong Ban; Zeng Yap; Emad Kandil; Cho Rok Lee; Sang-Wook Kang; Jandee Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.